Assistant Director
US FDA
Lydia Glaw is an Assistant Director in the Office of Cardiovascular Devices at FDA. She supervises the Coronary Interventional Devices Team, which reviews all US regulatory submissions relating to coronary stents, drug coated balloons, catheters and guidewires.
Disclosure information not submitted.
FDA Perspectives on Periprocedural MI in Trials Intended for Regulatory Review: What Has Changed?
Tuesday, March 12, 2024
11:48 AM – 11:56 AM ET
Panel Discussion: Defining Periprocedural MI in Clinical Trials
Tuesday, March 12, 2024
11:56 AM – 12:30 PM ET